Researchers from the University of Toledo have discovered a prospective new treatment for rheumatoid arthritis. The vaccine-based treatment strategy proved successful in preliminary animal studies and the researchers are looking to conduct more clinical trials in the future. The research hinges around a protein called 14-3-3 zeta. Ritu Chakravarti, lead author on the new study, has been studying 14-3-3 zeta for several years due to its suspected role in a number of autoimmune conditions. The initial hypothesis was this protein played a significant role in the onset of rheumatoid arthritis. If it was triggering the disease then knocking out the...